A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1

Patients with neurofibromatosis type 1 develop both benign and malignant tumors at an increased frequency. Most of the malignant peripheral nerve sheath tumors (MPNSTs) are considered as high-grade sarcomas originating from tissues of mesenchymal origin. It is generally accepted that MPNSTs occur in...

Full description

Bibliographic Details
Main Authors: Özmen Öztürk, Alper Tutkun
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Case Reports in Otolaryngology
Online Access:http://dx.doi.org/10.1155/2012/936735
id doaj-b912bdc637844955ac32a42b16ac6296
record_format Article
spelling doaj-b912bdc637844955ac32a42b16ac62962020-11-24T23:57:51ZengHindawi LimitedCase Reports in Otolaryngology2090-67652090-67732012-01-01201210.1155/2012/936735936735A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1Özmen Öztürk0Alper Tutkun1Department of Otorhinolaryngology, School of Medicine, Istanbul Medipol University, Istanbul, TurkeyDepartment of Otorhinolaryngology, Academic Hospital, Istanbul, TurkeyPatients with neurofibromatosis type 1 develop both benign and malignant tumors at an increased frequency. Most of the malignant peripheral nerve sheath tumors (MPNSTs) are considered as high-grade sarcomas originating from tissues of mesenchymal origin. It is generally accepted that MPNSTs occur in about 2% to 5% of neurofibromatosis patients. In this paper, we present a 16-year-old male patient with neurofibromatosis who developed MPNST of the retromolar area. The mass enlarged rapidly in a period of 6 weeks. The patient was treated surgically, and a tumor mass with a diameter of  cm was excised, but after 8 months a recurrence was observed at the same site. The sarcomatous change in a neurofibroma has an extremely poor prognosis, so patients with neurofibromatosis should be closely monitored for a possible malignancy. A rapid change in size of a preexisting neurofibroma, infiltration of the adjacent structures, intralesional hemorrhage, and pain indicate a possible malignant transformation to MPNST.http://dx.doi.org/10.1155/2012/936735
collection DOAJ
language English
format Article
sources DOAJ
author Özmen Öztürk
Alper Tutkun
spellingShingle Özmen Öztürk
Alper Tutkun
A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1
Case Reports in Otolaryngology
author_facet Özmen Öztürk
Alper Tutkun
author_sort Özmen Öztürk
title A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1
title_short A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1
title_full A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1
title_fullStr A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1
title_full_unstemmed A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1
title_sort case report of a malignant peripheral nerve sheath tumor of the oral cavity in neurofibromatosis type 1
publisher Hindawi Limited
series Case Reports in Otolaryngology
issn 2090-6765
2090-6773
publishDate 2012-01-01
description Patients with neurofibromatosis type 1 develop both benign and malignant tumors at an increased frequency. Most of the malignant peripheral nerve sheath tumors (MPNSTs) are considered as high-grade sarcomas originating from tissues of mesenchymal origin. It is generally accepted that MPNSTs occur in about 2% to 5% of neurofibromatosis patients. In this paper, we present a 16-year-old male patient with neurofibromatosis who developed MPNST of the retromolar area. The mass enlarged rapidly in a period of 6 weeks. The patient was treated surgically, and a tumor mass with a diameter of  cm was excised, but after 8 months a recurrence was observed at the same site. The sarcomatous change in a neurofibroma has an extremely poor prognosis, so patients with neurofibromatosis should be closely monitored for a possible malignancy. A rapid change in size of a preexisting neurofibroma, infiltration of the adjacent structures, intralesional hemorrhage, and pain indicate a possible malignant transformation to MPNST.
url http://dx.doi.org/10.1155/2012/936735
work_keys_str_mv AT ozmenozturk acasereportofamalignantperipheralnervesheathtumoroftheoralcavityinneurofibromatosistype1
AT alpertutkun acasereportofamalignantperipheralnervesheathtumoroftheoralcavityinneurofibromatosistype1
AT ozmenozturk casereportofamalignantperipheralnervesheathtumoroftheoralcavityinneurofibromatosistype1
AT alpertutkun casereportofamalignantperipheralnervesheathtumoroftheoralcavityinneurofibromatosistype1
_version_ 1725453076836384768